Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S1 from First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer
  1. Home
  2. Publications
  3. Supplementary Figure S1 from First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer

Supplementary Figure S1 from First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer

Authors:
  • TYTimothy A. Yap
    Timothy A. Yap
  • JGJonathan W. Goldman
    Jonathan W. Goldman
  • SVShaveta Vinayak
    Shaveta Vinayak
  • ATAntoaneta Tomova
    Antoaneta Tomova
  • EHErika Hamilton
    Erika Hamilton
  • YNYoichi Naito
    Yoichi Naito
  • AGAntonio Giordano
    Antonio Giordano
  • IBIgor Bondarenko
    Igor Bondarenko
  • TYToshinari Yamashita
    Toshinari Yamashita
  • LZLi Zhou
    Li Zhou
  • AMAllison Moreau
    Allison Moreau
  • HNHeather Neumann
    Heather Neumann

Open Access
Publisher website
Google Scholar
  • 15 July 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.29568389
Abstract
Supplementary Figure S1. Change from baseline in tumor biomarkers following monotherapy or combination treatment - biomarker analysis set.
Keywords
  • BREAST CANCER
  • CLINICAL TRIAL RESULTS
  • DRUG TARGETS
  • PROTEIN KINASE & PHOSPHATASE DRUG TARGETS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.